Polycystic Ovary Induction in Mouse by Testosterone Enanthate

نویسندگان

  • Zeinali, Hadis
چکیده مقاله:

Background &Objective: Polycystic ovary is the most common cause of infertility in Women. Animal models are required for understanding the pathogenesis of polycystic ovary. The objective of this study then was to develop an animal model for inducing the polycystic ovaries using testosterone enanthate.Materials & Methods: In this study, for inducing the polycystic ovary phenotype, female rats about12-14 days-old were injected daily with testosterone enanthate for 2 and 4 weeks (experiment groups: 1 and 2), while the control groups (1 and 2) were injected only with vehicle.The ovaries from both groups were fixed and then were used for histological studies.Results: Testosterone enanthate treatment causes the histological changes in mouse ovary and significantly increased the percentage of preantral and cystic follicles and decreased the percentage of antral follicles in the experiment group, comparing with the control group (P<0.05).Conclusion: It concluded that testosterone enanthate can induces polycystic ovary in mouse.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

P-65: Polycystic Ovary Syndrome Induction in NMRI Mice by Testosterone Enantate

Background: Polycystic ovary syndrome (PCOS) is a heterogeneous disease characterized by hyperandrogenaemia, hirsutism, oligo-or amenorrhea, and anovulation. A common feature of PCOS is the accumulation of small subcortical follicles and increased ovarian stromal volume, causing a characteristic ultrasound image and a basis for the most commonly used designation for the syndrome. In order to th...

متن کامل

Ovulation induction in polycystic ovary syndrome.

Management of polycystic ovary syndrome (PCOS) usually spans a woman's reproductive years. While treatment of androgenic symptoms is often a primary concern, periodically, the regimen has to be modified because of a desire for pregnancy. As these women are usually anovulatory, ovulation induction is generally required. The premise on which ovulation induction in PCOS is based is two-fold: incre...

متن کامل

Study of Zizyphus jujube L. fruit's hydroethanolic extract in rats with polycystic ovary syndrome

Background & aim: Polycystic ovary syndrom (PCOS) is one of the most common endocrine disorders which affect 5-10% of women in reproductive ages. Some of the medicinal plants are able to inhibit of  progressing or exhibit of PCOS. The aim of this study is investigation of  Zizyphus jujube L. fruit's hydroethanolic extract (ZHE) in rats with polycystic ovary syndrome. Methods: In this experiment...

متن کامل

Polycystic ovary syndrome. Polycystic ovary syndrome.

If you get the printed book in on-line book store, you may also find the same problem. So, you must move store to store and search for the available there. But, it will not happen here. The book that we will offer right here is the soft file concept. This is what make you can easily find and get this polycystic ovary syndrome polycystic ovary syndrome by reading this site. We offer you the best...

متن کامل

SOGC Clinical Practice Guideline Ovulation Induction in Polycystic Ovary Syndrome

Objective: To review current non-pharmacologic and pharmacologic options for ovulation induction in women with polycystic ovary syndrome (PCOS). Options: This guideline reviews the evidence for the various options for ovulation induction in PCOS. Outcomes: Ovulation, pregnancy and live birth rates, risks, and side effects are the outcomes of interest. Evidence: Published literature was retrieve...

متن کامل

Ovulation induction in polycystic ovary syndrome: Current options.

There are a variety of effective treatment options to induce ovulation in women with polycystic ovary syndrome (PCOS). The most effective treatments are primarily reproductive and target the hypothalamic-pituitary-ovarian (HPO) axis. Letrozole, an aromatase inhibitor, is headed toward replacing clomiphene, a selective estrogen receptor modulator, as the first-choice option. Metabolic treatments...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


عنوان ژورنال

دوره 3  شماره 4

صفحات  387- 391

تاریخ انتشار 2014-03

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

کلمات کلیدی

کلمات کلیدی برای این مقاله ارائه نشده است

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023